Aisling Capital Management LP Long-Term Concentrated

Location: New York, NY

CIK: 0001766721 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 10, 2022

Total Value: $185M (100.0% shares, 0.0% debt)

Holdings (21)

BBIO BridgeBio Pharma Inc. (BBIO) 33.2%

Value $61.59M Shares 6,068,125 Est. Cost $40.43 Unrealized -74.6%

GLUE Monte Rosa Therapeutics Inc. (GLUE) 11.1%

Value $20.64M Shares 1,472,331 Est. Cost $20.37 Unrealized -31.8%

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 9.6%

Value $17.82M Shares 1,025,000 Est. Cost $10.24 Unrealized +64.4%

HRMY Harmony Biosciences Holdings Inc. (HRMY) 9.0%

Value $16.68M Shares 342,815 Est. Cost $36.46 Unrealized +11.9%

NUVB Nuvation Bio Inc. (NUVB) 7.2%

Value $13.37M Shares 2,541,009 Est. Cost $11.18 Unrealized -49.8%

ACRS Aclaris Theraputics Inc. (ACRS) 5.9%

Value $10.94M Shares 634,455 Est. Cost $10.31 Unrealized +32.4%

— Elevation Oncology Inc. (ELEV) 3.9%

Value $7.144M Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Talaris Therapeutics Inc. (TALS) 3.6%

Value $6.72M Shares 682,923 Est. Cost $14.69 Unrealized —

— Verona Pharma plc (VRNA) 3.6%

Value $6.649M Shares 1,332,485 Est. Cost $7.38 Unrealized —

— Poseida Therapeutics Inc. (PSTX) 2.5%

Value $4.674M Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Aeglea Biotherapeutics Inc. (AGLE) 2.1%

Value $3.89M Shares 1,691,151 Est. Cost $8.00 Unrealized —

BMEA Biomea Fusion Inc. (BMEA) 1.9%

Value $3.562M Shares 798,757 Est. Cost $17.65 Unrealized -63.3%

— Reneo Pharmaceuticals Inc. (RPHM) 1.4%

Value $2.605M Shares 886,075 Est. Cost $9.33 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 1.3%

Value $2.423M Shares 1,205,511 Est. Cost $24.31 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 0.7%

Value $1.383M Shares 3,142,857 Est. Cost $4.35 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.7%

Value $1.374M Shares 288,571 Est. Cost $11.34 Unrealized —

— AVROBIO, Inc. (AVRO) 0.7%

Value $1.333M Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Atreca Inc. (BCEL) 0.7%

Value $1.229M Shares 387,653 Est. Cost $18.84 Unrealized —

— Zosano Pharma Corporation (ZSAN) 0.3%

Value $612K Shares 2,718,226 Est. Cost $2.15 Unrealized —

— ObsEva SA (OBSV) 0.3%

Value $596K Shares 394,838 Est. Cost $12.66 Unrealized —

— Nabriva Therapeutics plc (NBRV) 0.0%

Value $80,000 Shares 191,028 Est. Cost $1.66 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$61.59M	33.2%	$40.43	-74.6%	COM	10806X102
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$20.64M	11.1%	$20.37	-31.8%	COM	61225M102
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$17.82M	9.6%	$10.24	+64.4%	COM	87164F105
HRMY	Harmony Biosciences Holdings Inc. (HRMY)	342,815	$16.68M	9.0%	$36.46	+11.9%	COM	413197104
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$13.37M	7.2%	$11.18	-49.8%	COM CL A	67080N101
ACRS	Aclaris Theraputics Inc. (ACRS)	634,455	$10.94M	5.9%	$10.31	+32.4%	COM	00461U105
—	Elevation Oncology Inc. (ELEV)	2,834,910	$7.144M	3.9%	$13.57	—	COM	28623U101
—	Talaris Therapeutics Inc. (TALS)	682,923	$6.72M	3.6%	$14.69	—	COM	87410C104
—	Verona Pharma plc (VRNA)	1,332,485	$6.649M	3.6%	$7.38	—	SPONSORED ADS	925050106
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$4.674M	2.5%	$8.87	—	COM	73730P108
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$3.89M	2.1%	$8.00	—	COM	00773J103
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$3.562M	1.9%	$17.65	-63.3%	COM	09077A106
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$2.605M	1.4%	$9.33	—	COM	75974E103
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$2.423M	1.3%	$24.31	—	COM	85209E109
—	Marker Therapeutics, Inc. (MRKR)	3,142,857	$1.383M	0.7%	$4.35	—	COM	57055L107
—	Viracta Therapeutics Inc. (VIRX)	288,571	$1.374M	0.7%	$11.34	—	COM	92765F108
—	AVROBIO, Inc. (AVRO)	1,009,779	$1.333M	0.7%	$16.72	—	COM	05455M100
—	Atreca Inc. (BCEL)	387,653	$1.229M	0.7%	$18.84	—	CL A COM	04965G109
—	Zosano Pharma Corporation (ZSAN)	2,718,226	$612K	0.3%	$2.15	—	COM NEW	98979H202
—	ObsEva SA (OBSV)	394,838	$596K	0.3%	$12.66	—	COM	H5861P103
—	Nabriva Therapeutics plc (NBRV)	191,028	$80,000	0.0%	$1.66	—	SHS	G63637113